À la découverte de l'ézétimibe = EzetimibeWATKINS, C.La Lettre du cardiologue. 2004, Num 378, pp 44-45, issn 0761-5035, 2 p.Article

Simultaneous Liquid Chromatographic Determination of Ezetimibe and Simvastatin in Pharmaceutical ProductsRENATO OLIVEIRA, Paulo; BARTH, Thiago; TODESCHINI, Vitor et al.Journal of AOAC International. 2007, Vol 90, Num 6, pp 1566-1572, issn 1060-3271, 7 p.Article

Effectiveness of Thrice Weekly EzetimibeVENERO, Carmelo V; VENERO, Jose V; SEIP, Richard L et al.The American journal of cardiology. 2008, Vol 102, Num 9, pp 1205-1206, issn 0002-9149, 2 p.Article

Données récentes sur l'EzetimibeCAZAUBON, M; AZAR, R.Angéiologie (Paris). 2010, Vol 62, Num 4, pp 42-43, issn 0003-3049, 2 p.Article

Ezetimibe Is an Inhibitor of Tumor AngiogenesisSOLOMON, Keith R; PELTON, Kristine; BOUCHER, Kelly et al.The American journal of pathology. 2009, Vol 174, Num 3, pp 1017-1026, issn 0002-9440, 10 p.Article

Ezetimibe-Associated Immune ThrombocytopeniaPATTIS, Peter; WIEDERMANN, Christian J.The Annals of pharmacotherapy. 2008, Vol 42, Num 3, pp 430-433, issn 1060-0280, 4 p.Article

Ezetimibe : A review of its metabolism, pharmacokinetics and drug interactionsKOSOGLOU, Teddy; STATKEVICH, Paul; JOHNSON-LEVONAS, Amy O et al.Clinical pharmacokinetics. 2005, Vol 44, Num 5, pp 467-494, issn 0312-5963, 28 p.Article

Stability-indicating reversed-phase liquid chromatographic method for simultaneous determination of simvastatin and ezetimibe from their combination drug productsCHAUDHARI, Bharat G; PATEL, Natvarlal M; SHAH, Paresh B et al.Journal of AOAC International. 2007, Vol 90, Num 5, pp 1242-1249, issn 1060-3271, 8 p.Article

Initial low-density lipoprotein response to statin therapy predicts subsequent low-density lipoprotein response to the addition of ezetimibeZIAJKA, Paul E; REIS, Mary; KREUL, Sandra et al.The American journal of cardiology. 2004, Vol 93, Num 6, pp 779-780, issn 0002-9149, 2 p.Article

Diastereoselective reduction of 1-(4-fluorophenyl)-3(R)-[3-oxo-3-(4-fluorophenyl)-propyl]-4(S)-(4-hydroxyphenyl)azetidin-2-one to Ezetimibe by the whole cell catalyst Rhodococcus fascians MO22KYSLIKOVA, Eva; BABIAK, Peter; MARESOVA, Helena et al.Journal of molecular catalysis. B, Enzymatic. 2010, Vol 67, Num 3-4, pp 266-270, issn 1381-1177, 5 p.Article

In-vitro characterization of the six clustered variants of NPC1 L1 observed in cholesterol low absorbersYAMANASHI, Yoshihide; TAKADA, Tappei; SUZUKI, Hiroshi et al.Pharmacogenetics and genomics (Print). 2009, Vol 19, Num 11, pp 884-892, issn 1744-6872, 9 p.Article

Effects of Mixed Micellar Lipids on Carotenoid Uptake by Human Intestinal Caco-2 CellsKOTAKE-NARA, Eiichi; NAGAO, Akihiko.Bioscience, biotechnology, and biochemistry. 2012, Vol 76, Num 5, pp 875-882, issn 0916-8451, 8 p.Article

Lack of clinically relevant drug-drug interactions when dalcetrapib is co-administered with ezetimibeDERKS, Michael; ABT, Markus; PHELAN, Mary et al.British journal of clinical pharmacology. 2010, Vol 70, Num 6, pp 825-833, issn 0306-5251, 9 p.Article

Burkholderia cenocepacia: a new biocatalyst for efficient bioreduction of ezetimibe intermediateSINGH, Amit; BASIT, Abdul; BANERJEE, Uttam C et al.Journal of industrial microbiology & biotechnology. 2009, Vol 36, Num 11, pp 1369-1374, issn 1367-5435, 6 p.Article

Ezetimibe effectively decreases LDL-cholesterol in HIV-infected patientsCOLL, Blai; ARAGONES, Gerard; PARRA, Sandra et al.AIDS (London). 2006, Vol 20, Num 12, pp 1675-1677, issn 0269-9370, 3 p.Article

Striated muscle safety of Ezetimibe/Simvastatin (Vytorin)DAVIDSON, Michael H; MACCUBBIN, Darbie; STEPANAVAGE, Michael et al.The American journal of cardiology. 2006, Vol 97, Num 2, pp 223-228, issn 0002-9149, 6 p.Article

Safety profile of statins alone or combined with ezetimibe: a pooled analysis of 27 studies including over 22,000 patients treated for 6―24 weeksTOTH, P. P; MORRONE, D; WEINTRAUB, W. S et al.International journal of clinical practice (Esher). 2012, Vol 66, Num 8, pp 800-812, issn 1368-5031, 13 p.Article

Drug Interactions Between the ImmunosuppressantTacrolimus and the Cholesterol Absorption Inhibitor Ezetimibe in Healthy VolunteersOSWALD, S; NASSIF, A; SIEGMUND, W et al.Clinical pharmacology and therapeutics. 2011, Vol 89, Num 4, pp 524-528, issn 0009-9236, 5 p.Article

Structure of the major degradant of ezetimibeSANTA, Zsuzsanna; KOTI, Janos; SZOKE, Katalin et al.Journal of pharmaceutical and biomedical analysis. 2012, Vol 58, pp 125-129, issn 0731-7085, 5 p.Article

Complex Pharmacokinetic Behavior of Ezetimibe Depends on Abcc2, Abcc3, and Abcg2DE WAART, Dirk R; VLAMING, Maria L. H; KUNNE, Cindy et al.Drug metabolism and disposition. 2009, Vol 37, Num 8, pp 1698-1702, issn 0090-9556, 5 p.Article

Impact of Ezetimibe on Atherosclerosis : Is the Jury Still Out?AL BADARIN, Firas J; KULLO, Iftikhar J; KOPECKY, Stephen L et al.Mayo Clinic proceedings. 2009, Vol 84, Num 4, pp 353-361, issn 0025-6196, 9 p.Article

Disposition of ezetimibe is influenced by polymorphisms of the hepatic uptake carrier OATP1B1OSWALD, Stefan; KÖNIG, Jörg; LÜTJOHANN, Dieter et al.Pharmacogenetics and genomics (Print). 2008, Vol 18, Num 7, pp 559-568, issn 1744-6872, 10 p.Article

Use of Ezetimibe in the United States and CanadaJACKEVICIUS, Cynthia A; TU, Jack V; ROSS, Joseph S et al.The New England journal of medicine. 2008, Vol 358, Num 17, pp 1819-1828, issn 0028-4793, 10 p.Article

Tendon rupture associated with Simvastatin/ezetimibe therapyPULLATT, Raja C; REDDY GADARLA, Mamatha; KARAS, Richard H et al.The American journal of cardiology. 2007, Vol 100, Num 1, pp 152-153, issn 0002-9149, 2 p.Article

L'ézétimibe (Ezetrol®) : le partenaire des statines = Ezetimibe (Ezetrol®): the statins' partnerDUCOBU, J; STERNON, J.Revue médicale de Bruxelles. 2004, Vol 25, Num 5, pp 456-461, issn 0035-3639, 6 p.Article